Bastard P, Rosen L, Zhang Q, Michailidis E, Hoffmann H, Zhang Y, Dorgham K, Philippot Q, Rosain J, Béziat V, Manry J, Shaw E, Haljasmägi L, Peterson P, Lorenzo L, Bizien L, Trouillet-Assant S, Dobbs K, de Jesus A, Belot A, Kallaste A, Catherinot E, Tandjaoui-Lambiotte Y, Le Pen J, Kerner G, Bigio B, Seeleuthner Y, Yang R, Bolze A, Spaan A, Delmonte O, Abers M, Aiuti A, Casari G, Lampasona V, Piemonti L, Ciceri F, Bilguvar K, Lifton R, Vasse M, Smadja D, Migaud M, Hadjadj J, Terrier B, Duffy D, Quintana-Murci L, van de Beek D, Roussel L, Vinh D, Tangye S, Haerynck F, Dalmau D, Martinez-Picado J, Brodin P, Nussenzweig M, Boisson-Dupuis S, Rodríguez-Gallego C, Vogt G, Mogensen T, Oler A, Gu J, Burbelo P, Cohen J, Biondi A, Bettini L, D'Angio M, Bonfanti P, Rossignol P, Mayaux J, Rieux-Laucat F, Husebye E, Fusco F, Ursini M, Imberti L, Sottini A, Paghera S, Quiros-Roldan E, Rossi C, Castagnoli R, Montagna D, Licari A, Marseglia G, Duval X, Ghosn J, Tsang J, Goldbach-Mansky R, Kisand K, Lionakis M, Puel A, Zhang S, Holland S, Gorochov G, Jouanguy E, Rice C, Cobat A, Notarangelo L, Abel L, Su H and Casanova J (2020) Autoantibodies against type I IFNs in patients with life-threatening COVID-19, Science, 10.1126/science.abd4585, 370 :6515, (eabd4585), Online publication date: 2.
0 kommentar(er)
